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Abstract: 
Isolation of Ureaplasma spp. from preterm neonates and the association with 
development of bronchopulmonary dysplasia has been previously investigated. 
However, few studies have contrasted the nature of infection in twins.  Here we report 
that dizygotic twins (1 female, 1 male) born at 24 weeks gestation both yielded 
culturable Ureaplasma from endotracheal secretions.  The samples were part of a 
serial blind collection cohort of ventilated premature neonates, and analysis of repeat 
cultures showed stable separate infections over a period of 17 and 21 days 
respectively.  Immunoblot and probe-specific qPCR analysis determined that Twin1 
was solely infected with Ureaplasma parvum (specifically serovar 6 by gene 
sequencing), while Twin2 was solely infected with Ureaplasma urealyticum 
(specifically genotype A- serovars 2, 5, and 8 by gene sequencing).  Immunoblot 
analysis found that the major surface antigen (multiple-banded antigen; MBA) altered 
relative mass for both strains during the course of infection. Quantitative PCR 
analysis of extracted endotracheal aspirates confirmed no evidence of mixed infection 
for either twin.  Failure of sentinel ventilated preterm infants on the same ward to 
acquire Ureaplasma infection after the first week of birth suggest no cot-to-cot 
transfer of Ureaplasma infection occurred.  This study demonstrated not only a 
contrasting clinical outcome for a set of twins infected with two separate species of 
Ureaplasma, but also the first real-time demonstration of MBA alteration and 
evolution of Ureaplasma over the course of a clinical infection. 
Introduction: 
The Office for National Statistics has reported a steady rate of preterm birth (<37 
weeks gestation) of 7.1-7.3% since 2009 in the UK.  Those born <28 weeks gestation 
(early preterm; ePTB) are of greatest clinical significance; 66% of which are 
associated with chorioamnionitis and Ureaplasma spp. are the most common 
microorganisms isolated from cases of ePTB.1, 2 Furthermore, respiratory Ureaplasma 
spp. infection is found to be concentrated (up to 65%) in ventilated ePTB postnatally.3 
However, the mechanism by which Ureaplasma gain entry to the amniotic sac as well 
as the differential pathogenicity of the two species is still under debate.   
 
Only two previous twin studies on intrauterine infection or chorioamnionitis have 
examined Ureaplasma spp, but preferential infection of the presenting twin has been 
reported.4, 5  Here we present a unique case study examining repeated endotracheal 
samples where each twin was solely infected with a separate species of Ureaplasma, 
with different clinical outcomes as well as evidence of bacterial evolution during 
infection.  
 
 
Methods: 
Patient details and ethical approval 
The mother was fit and well, her first pregnancy, a non-smoker during pregnancy with 
no abnormal antenatal serology.   She presented with spontaneous onset of labour at 
24 +4 weeks gestation followed by vaginal delivery of twins (Twin1 cephalic – 
female and Twin2 breech - male). 
 
Twin1 was transferred from birth hospital to nearest tertiary neonatal intensive care 
unit (NICU) on day 1. She was extubated on day 20 to continuous positive airways 
pressure (CPAP) after commencing diuretics, but as a result of increasing apnoeas, 
bradycardias and desaturations required re-intubation on day 23. Re-intubation was 
accompanied by administration of antibiotics (teicoplanin and gentamicin). The twin 
was extubated on day 31. 
 
Due to high ventilation requirements and recurrent pulmonary haemorrhages Twin1 
was too unstable to transfer on day 1 and arrived at the NICU on day 5.  This infant 
remained on ventilation until his death on day 32.  Primary cause of death was 
determined as necrotising enterocolitis (NEC) with secondary causes listed as 
prematurity, chronic lung disease of prematurity and intracranial haemorrhage. No 
data on chorioamnioitis was available. 
 
Ethical consent was received and approved by local ethics board 
 
Sample transport and culture methods. 
Endotracheal aspirates (ETA) samples were taken as part of the Ureatrack study and 
were transported to University Hospital of Wales, Cardiff, for analysis. Infectious 
Ureaplasma spp. titre was determined by culture in Ureaplasma selective media 
(USM) (Mycoplasma Experience, UK) in triplicate upon arrival, while aliquots were 
frozen (-80oC) for later DNA extraction and quantitative PCR determination of U. 
parvum, U. urealyticum and M. hominis genomes at Public Health England by 
published methods.6, 7 
 
Analysis of Ureaplasma isolates 
Positive cultures from each sample were subjected to Ureaplasma spp. PCR 
genotyping analysis and results were confirmed by sequencing the purified DNA 
amplicons (Eurofins MWG, Germany).8 Cultured Ureaplasma isolates from each 
positive patient sample were also analysed by previously published immunoblot 
analysis, using a panel of characterised monoclonal antibodies (Virostat, Portland, 
ME) that recognise the serovar-determining multiple-banded antigen (MBA) 
[submitted manuscript] that can differentiate between Ureaplasma parvum and 
Urealyticum urealyticum as well as some serovars.9 MBA protein mass was 
determined relative to PageRuler™ protein mass standards (ThermoFisher, UK).  
 
Results: 
  
Culture and qPCR data graphs 
Bacterial loads were quantified by both culture and multiplex real-time qPCR.  Values 
for bacterial load over the course of infection followed a similar pattern by each 
method.  ETA samples from Twin1 were negative for U. parvum on day 1 (Figure 1), 
but progressively increased in titre with a maximum load of 104 CCU on day 10. 
Titres then dropped by day 24 with a final negative result.  The first sample for Twin2 
on day 12 was strongly positive for Ureaplasma with 104 CCU, but became 
increasingly positive with high titres of 107 CCU (2.8 x105 copies/µl U. urealyticum) 
until the patient died.   
 
Species determination of Ply130 and Ply131 
Analysis methods (primer-probe pairs from qPCR, amplification by speciation PCR 
primers, species-specific monoclonal antibodies by immunoblot analysis), 
demonstrated that all culture positive samples from Twin1 contained only U. parvum 
(designated strain Ply130) while all culture positive samples from Twin2 contained 
only U. urealyticum (designated strain Ply131).  There was no contamination of any 
sample by the alternate Ureaplasma species or Mycoplasma hominis as confirmed by 
qPCR. 
 
Analysis of the MBA surface antigen over the course of infection 
Immunoblot analysis using monoclonal antibodies that detect both U. urealyticum and 
U. parvum (clone 6522; Figure 2A) or specifically U. parvum (clones 6523; Figure 
2B) found that the surface MBA protein changed considerably over the course of 
infection.  A single discrete band of approximately 80 kDa was initially noted for 
strain Ply130 on day four post-birth which was accompanied by a second larger band 
of 100 kDa by day six.  At day ten a further two bands were apparent (36 kDa and 50 
kDa) and were the predominant MBA species until day 23. For isolate Ply131 a single 
MBA species of 60 kDa was seen on days 12 and 18 post birth, but this was replaced 
by two bands of 50 kDa and 130 kDa.  The larger 130 kDa band was then present 
until the final sample prior to patient death.   
  
 
 
 
Discussion: 
We present a case study of dizygotic twins both with Ureaplasma positive 
endotracheal aspirate samples, but interestingly harbouring two separate species.  Of 
particular interest is the observed alteration to the bacterial major surface antigen 
mass over the course of infection.   
 
For Twin1 the titres of U. parvum (Ply130) obtained from samples rapidly increased 
from the first sample, but a sample taken on day 24 failed to grow Ureaplasma by 
culture, despite detection of residual bacterial genomic DNA by the sensitive PCR 
methods. Although this culture-negative result coincided with the administration of 
teicoplanin and gentamicin this will not have an impact on the Ureaplasma 
colonisation status due to the pathogen’s intrinsic resistance to these antibiotics.10   
 
The first sample for Twin2 was not taken until 10 days after birth as poor patient 
clinical status precluded transport to the research hospital.  While U. urealyticum was 
not detected in the initial sample, high levels of  U. urealyticum were present in a 
sample taken three days later and all subsequent samples tested until the death of the 
patient 21 days later as a result of NEC. Ureaplasma spp. infection have been 
reported to contribute to the development of NEC. Ureaplasma has been detected in 
gastric aspirate samples from preterm human neonates, and experimental intrauterine 
Ureaplasma infection in pregnant sheep was found to impair development of the fetal 
ovine gut in an IL-1-dependent manner.11, 12 Further, Okogbule-Wonodi et al., have 
reported a 2-fold increased NEC prevalence in Ureaplasma-infected neonates born 
<33 weeks and a 3.3-fold increase those born <28 weeks with Ureaplasma infection.13    
 
The greater pathogenic potential of U. urealyticum relative to U. parvum has been 
reported among urethritis patients as well as individuals presenting with miscarriage 
which is consistent with the worse clinical outcome for Twin2 compared to Twin1.14, 
15
  
 
The repeated sampling nature of this study gave a unique opportunity to track the 
evolution of antigen variability of each Ureaplasma strain throughout the course of 
the infection.  Altered mass of the MBA, caused by insertion or deletion of repeat 
units in the external portion of the protein, is likely in response to host immune 
response especially since immunoglobulin and complement have been shown 
important to Ureaplasma-cidal activity of human sera.16,12 This is the first real-time 
demonstration of MBA alteration in a clinical infection: The U. parvum MBA from 
the strain infecting Twin1 decreased in mass, while the U. urealyticum from Twin2 
increased.  An increase in molecular weight of the major surface antigen has been 
shown to be important to evading complement-mediated killing by serum in the 
closely related species Mycoplasma pulmonis.17  Future studies will collect serum 
samples from mothers and neonates, in parallel to ETS samples, to determine if MBA 
alteration coincides with altered serum killing of matched Ureaplasma isolates. 
 
Previous reports have shown discordance in microbial infection between twins. In 
1990, Romero and colleagues performed amniocentesis on women carrying twins 
with intact membranes, presenting with preterm labour.4 Of the five pairs with 
evidence of microbial invasion of the amniotic cavity that subsequently delivered 
preterm, Ureaplasma spp. was cultured from three of these pairs and invariably only 
from the presenting (never from the non-presenting) twin. Unfortunately this study 
predated the differentiation of Ureaplasma species.  In a second study by Mazor et 
al., examining microbial invasion of preterm twins, only the presenting twin was 
infected in five out of nine cases, and microbial titre was always higher for the 
presenting twin in the remaining cases where both twins were infected.18 Ureaplasma 
spp. were the most commonly observed pathogen in this study. These data suggest 
that microbial invasion occurs via ascending infection, and a retrospective study on 
chorioamnionitis and funisitis examining 1156 twins found that dichorionic placentas 
conferred significant protection against the spread of chorioamnionitis from the 
presenting to the non-presenting gestational sac.5   
 
In conclusion we report the first known case of twins independently infected with 
different Ureaplasma species, where different clinical outcomes were observed and 
both bacterial species showed antigenic evolution across serial samples.  
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Figure 1. Quantification of Ureaplasma spp. from endotracheal aspirated during the 
course of infection. Ureaplasma spp. were quantified by both real-time q-PCR 
(solid line) and routine colour changing units (CCU) (dashed line). U. parvum 
(square) was isolated from Twin1 and U. urealyticum (triangle) was isolated from 
Twin2.  
 
 
Figure 2. Immunoblot analysis of the multiple-banded antigen of Ureaplasma 
isolated from endotracheal secretions from Twin1 and Twin2. The multiple-banded 
antigen was detected with monoclonal antibody 6522 (recognises both U. parvum and 
U. urealyticum) (A). Monoclonal antibody 6523 (U. parvum specific) detected the 
isolates from Twin1, but not Twin2 (B). 
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Figure 1. Quantification of Ureaplasma spp. from endotracheal aspirated during the 
course of infection.  Ureaplasma spp. load was quantified by both real-time q-PCR 
(dashed line) and routine colour changing units (solid line). Final sample for Twin 1 
represents point of extubation whereas final sample for Twin 2 represents end of life. 
U. parvum (square) was isolated from Twin1 and U. urealyticum (triangle) was 
isolated from Twin2. CCU = colour changing units (bacterial growth measurement). 
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Figure 2. Immunoblot analysis of the multiple-banded antigen of Ureaplasma strains 
isolated from endotracheal secretions from Twin1 and Twin2. The major surface 
antigen (multiple-banded antigen) detected by incubation with monoclonal antibody 
6522 that recognises a core epitope conserved in both U. parvum and U. urealyticum 
(A). Stripping and re-probing the blot with a monoclonal antibody that only recognises 
the multiple banded antigen for U. parvum (6523) detected the isolates from Twin1, but 
not Twin2 (B).  
